According to the American Society of Clinical Oncology, approximately 60% to 75% of women with breast cancer have estrogen receptor–positive breast cancer and 65% of these cancers are also progesterone receptor (PR) positive [2]. This evidence concerns the gene ESR1 and breast carcinoma.